Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.

8. Leib E, Restivo C, Paulus H. Immunosuppressive and corticoAdjuvant medical treatment steroid therapy of polyarteritis nodosa. Am J Med 1979; 67: 941–947 9. Cohen R, Conn D, Ilstrup D. Clinical features, prognosis and Specific treatments are sometimes required. response to treatment in polyarteritis. Mayo Clin Proc 1980; Hypertension is frequent in patients suffering from 55: 146–155 renal vasculitis. Angiotensin converting enzyme inhib10. Guillevin L, Jarrousse B, Lok C et al. Long-term followup after itors or angiotensin II-receptor blockers are effective treatment of polyarteritis nodosa and Churg–Strauss angiitis and able to control severe or malignant hypertension. with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective ranChronic renal failure may occur several months or domized trial of 71 patients. The Cooperative Study Group for years after recovery from PAN and is attributable to Polyarteritis Nodosa. J Rheumatol 1991; 18: 567–574 renal scars. In patients with neurological sequelae, no 11. Guillevin L, Lhote F, Jarrousse B, Fain O. Treatment of specific treatment is available; physical rehabilitation polyarteritis nodosa and Churg–Strauss syndrome. A metaanalysis of 3 prospective controlled trials including 182 patients can prevent deformities and enable functional posiover 12 years. Ann Méd Interne (Paris) 1992; 143: 405–416 tioning of the hands or feet, for example. Neurological 12. Luqmani R, Exley A, Kitas G, Bacon P. Disease assessment recovery may occur several months after the onset of and management of the vasculitides. Baillere’s Clin Rheumatol the treatment. 1997; 11: 423–446 13. Gayraud M, Guillevin L, Cohen P et al. Treatment of goodprognosis polyarteritis nodosa and Churg–Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in References 25 patients. Br J Rheumatol 1997; 36: 1290–1297 14. Guillevin L, Lhote F, Cohen P et al. Corticosteroids plus pulse 1. Kussmaul A, Maier K. Über eine nicht bisher beschriebene cyclophosphamide and plasma exchanges versus corticosteroids eigenthümliche Arterienerkrankung (Periarteritis Nodosa), die plus pulse cyclophosphamide alone in the treatment of polyartermit Morbus Brightii und rapid fortschreitender allgemeiner itis nodosa and Churg–Strauss syndrome patients with factors Muskellähmung einhergeht. Dtsch Arch Klin Med 1866; 1: predicting poor prognosis. A prospective, randomized trial in 484–518 sixty-two patients. Arthritis Rheum 1995; 38: 1638–1645 2. Frohnert P, Sheps S. Long-term follow-up study of polyarteritis 15. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener’s granulonodosa. Am J Med 1967; 48: 8–14 matosis: an analysis of 158 patients. Ann Intern Med 1992; 3. Fauci A, Doppman J, Wolff S. Cyclophosphamide-induced 116: 488–498 remission in advanced polyarteritis nodosa. Am J Med 1978; 16. Trépo C, Thivolet J. Antigen Australia, hépatite à virus et 64: 890–894 périartérite noueuse. Presse Méd 1970; 78: 1575 4. Guillevin L, Lhote F. Treatment of polyarteritis nodosa and 17. Finkel TH, Torok TJ, Ferguson PJ et al. Chronic parvovirus microscopic polyangiitis. Arthritis Rheum 1998; 41: 2100–2105 B19 infection and systemic necrotising vasculitis: opportunistic 5. Guillevin L, Lhote F, Gayraud M et al. Prognostic factors in infection or aetiological agent? Lancet 1994; 343: 1255–1258 polyarteritis nodosa and Churg–Strauss syndrome. A prospect18. Gisselbrecht M, Cohen P, Lortholoary O et al. Human immunoive study in 342 patients. Medicine (Baltimore) 1996; 75: 17–28 deficiency virus-related vasculitis. Clinical presentation of and 6. Guillevin L, Lhote F, Cohen P et al. Polyarteritis nodosa related therapeutic approach to eight cases. Ann Méd Interne (Paris) to hepatitis B virus. A prospective study with long-term observa1998; 149: 398–405 tion of 41 patients. Medicine (Baltimore) 1995; 74: 238–253 19. Guillevin L, Lhote F, Gallais V et al. Gastrointestinal tract 7. Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoinvolvement in polyarteritis nodosa and Churg–Strauss synplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675–682 drome. Ann Méd Interne (Paris) 1995; 146: 260–267